NCT03330275View on ClinicalTrials.gov

Evaluating the Impact of JJVC Senofilcon A - Based Contact Lens With New UV-blocker on Day and Night Driving Performance

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 27, 2017

Primary Completion Date

December 11, 2017

Study Completion Date

December 11, 2017

Conditions
Visual Performance
Interventions
DEVICE

Investigational Contact Lens

JJVC senofilcon A-based contact lens with new UV-blocker

DEVICE

Commercial ACUVUE OASYS

senofilcon A

DEVICE

Commercial ACUVUE OASYS and Spectacles

Senofilcon A and Spectacles

Trial Locations (1)

Unknown

Queensland University of Technology, School of Optometry and Vision Science, Brisbane

All Listed Sponsors
lead

Johnson & Johnson Vision Care, Inc.

INDUSTRY

NCT03330275 - Evaluating the Impact of JJVC Senofilcon A - Based Contact Lens With New UV-blocker on Day and Night Driving Performance | Biotech Hunter | Biotech Hunter